Those who are now complaining about dilution and issuing shares to fund the recent acquisitions clearly didn't do their homework. Gerald told us verbally and in print his plans for the increase in authorized shares. Some only heard or saw what they wanted to hear or see.
http://www.thechairmansblog.com/amarantus-bio...-strategy/Quote:As of this date, however, the Company requires additional authorized shares to assure the capital markets and investors that the Company has adequate common shares available to complete M&A activity if an attractive opportunity presents itself, raise additional funds if needed, and offer adequate equity compensation to enable recruitment of the best talent the Company will be seeking to bring on full-time as employees. The Company has been advised by various stakeholders in the larger capital markets community that it is best for the Company to achieve an appropriate capital structure while still on the OTC Markets so that the cap structure risk is mitigated once on a national exchange. In addition to an increase in the number of our authorized shares, we are seeking shareholder approval for various other matters that will better position the Company for the up-list to a national exchange.
He also described these goals in the Sept. 2014 business update call in response to a question posed by JPetro. Some act as if the use of shares in the ensuing acquisitions was somehow counter to what was previously claimed. Hogwash. I realize the company was looking for non-dilutive means as preferable options, but they clearly described the need for additional shares to include acquisitions.
